PortfoliosLab logo

Akero Therapeutics, Inc. (AKRO)

Equity · Currency in USD · Last updated Apr 1, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Akero Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $20,884 for a total return of roughly 108.84%. All prices are adjusted for splits and dividends.

AKRO (Akero Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AKRO

Akero Therapeutics, Inc.


Akero Therapeutics, Inc. had a return of -30.18% year-to-date (YTD) and 162.05% in the last 12 months. Over the past 10 years, Akero Therapeutics, Inc. had an annualized return of 21.52%, outperforming the S&P 500 benchmark which had an annualized return of 9.13%.

1 month-15.93%3.51%
6 months28.39%12.88%
1 year162.05%-10.71%
5 years (annualized)21.52%9.13%
10 years (annualized)21.52%9.13%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Akero Therapeutics, Inc. Sharpe ratio is 1.04. A Sharpe ratio greater than 1.0 is considered acceptable.

The chart below displays rolling 12-month Sharpe Ratio.

AKRO (Akero Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History

Akero Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

AKRO (Akero Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Akero Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Akero Therapeutics, Inc. is 79.96%, recorded on Jun 1, 2022. It took 93 trading sessions for the portfolio to recover.



To Bottom


To Recover



-79.96%Jul 10, 2020478Jun 1, 202293Oct 13, 2022571
-57.16%Aug 29, 2019139Mar 18, 202073Jul 1, 2020212
-31.99%Jan 3, 202354Mar 21, 2023
-17.41%Dec 19, 20221Dec 19, 20223Dec 22, 20224
-14.83%Jun 27, 20199Jul 10, 20192Jul 12, 201911
-13.27%Oct 25, 202210Nov 7, 20226Nov 15, 202216
-10.67%Dec 1, 20224Dec 6, 20228Dec 16, 202212
-9.04%Jul 29, 20192Jul 30, 20196Aug 7, 20198
-8.22%Jun 24, 20192Jun 25, 20191Jun 26, 20193
-7.35%Aug 8, 20192Aug 9, 20198Aug 21, 201910

Volatility Chart

Current Akero Therapeutics, Inc. volatility is 70.51%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

AKRO (Akero Therapeutics, Inc.)
Benchmark (^GSPC)